Literature DB >> 18468488

CTLA-4 trafficking and surface expression.

Elke Valk1, Christopher E Rudd, Helga Schneider.   

Abstract

The T-cell co-receptor cytotoxic T-cell antigen 4 (CTLA-4) has a strong inhibitory role as shown by the lymphoproliferative phenotype of CTLA-4-deficient mice. Despite its potent effects on T-cell function, CTLA-4 is primarily an intracellular antigen whose surface expression is tightly regulated by restricted trafficking to the cell surface and rapid internalisation. Recently, several signalling molecules such as Trim, PLD, ARF-1 and TIRC7 have been described to be involved in the transport of CTLA-4 to the cell surface. Minor changes in surface expression levels have major effects on the outcome of T-cell activation. Optimal regulation of CTLA-4 surface expression is crucial for the balance of stimulatory and inhibitory signals to maximize protective immune responses while maintaining immunological tolerance and preventing autoimmunity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18468488      PMCID: PMC4186961          DOI: 10.1016/j.it.2008.02.011

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  78 in total

1.  Regulation of cell surface expression of CTLA-4 by secretion of CTLA-4-containing lysosomes upon activation of CD4+ T cells.

Authors:  T Iida; H Ohno; C Nakaseko; M Sakuma; M Takeda-Ezaki; H Arase; E Kominami; T Fujisawa; T Saito
Journal:  J Immunol       Date:  2000-11-01       Impact factor: 5.422

2.  Induction of the CTLA-4 gene in human lymphocytes is dependent on NFAT binding the proximal promoter.

Authors:  Heather M Gibson; Carrie J Hedgcock; Barbara M Aufiero; Adam J Wilson; Mikehl S Hafner; George C Tsokos; Henry K Wong
Journal:  J Immunol       Date:  2007-09-15       Impact factor: 5.422

3.  Prevention of acute allograft rejection by antibody targeting of TIRC7, a novel T cell membrane protein.

Authors:  N Utku; T Heinemann; S G Tullius; G C Bulwin; S Beinke; R S Blumberg; F Beato; J Randall; R Kojima; L Busconi; E S Robertson; R Schülein; H D Volk; E L Milford; S R Gullans
Journal:  Immunity       Date:  1998-10       Impact factor: 31.745

4.  CD28 receptor endocytosis is targeted by mutations that disrupt phosphatidylinositol 3-kinase binding and costimulation.

Authors:  D Céfaï; H Schneider; O Matangkasombut; H Kang; J Brody; C E Rudd
Journal:  J Immunol       Date:  1998-03-01       Impact factor: 5.422

5.  Defective CTLA-4 cycling pathway in Chediak-Higashi syndrome: a possible mechanism for deregulation of T lymphocyte activation.

Authors:  F J Barrat; F Le Deist; M Benkerrou; P Bousso; J Feldmann; A Fischer; G de Saint Basile
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-20       Impact factor: 11.205

6.  Regulation of CTLA-4 expression during T cell activation.

Authors:  D Perkins; Z Wang; C Donovan; H He; D Mark; G Guan; Y Wang; T Walunas; J Bluestone; J Listman; P W Finn
Journal:  J Immunol       Date:  1996-06-01       Impact factor: 5.422

7.  An autoimmune disease-associated CTLA-4 splice variant lacking the B7 binding domain signals negatively in T cells.

Authors:  Lalitha Vijayakrishnan; Jacqueline M Slavik; Zsolt Illés; Rebecca J Greenwald; Dan Rainbow; Bernhard Greve; Laurence B Peterson; David A Hafler; Gordon J Freeman; Arlene H Sharpe; Linda S Wicker; Vijay K Kuchroo
Journal:  Immunity       Date:  2004-05       Impact factor: 31.745

8.  Regulation of indoleamine 2,3-dioxygenase and tryptophanyl-tRNA-synthetase by CTLA-4-Fc in human CD4+ T cells.

Authors:  Adriano Boasso; Jean-Philippe Herbeuval; Andrew W Hardy; Christiana Winkler; Gene M Shearer
Journal:  Blood       Date:  2004-10-05       Impact factor: 22.113

9.  Cytotoxic T lymphocyte antigen 4 and CD28 modulate cell surface raft expression in their regulation of T cell function.

Authors:  M Martin; H Schneider; A Azouz; C E Rudd
Journal:  J Exp Med       Date:  2001-12-03       Impact factor: 14.307

10.  Engagement of cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) induces transforming growth factor beta (TGF-beta) production by murine CD4(+) T cells.

Authors:  W Chen; W Jin; S M Wahl
Journal:  J Exp Med       Date:  1998-11-16       Impact factor: 14.307

View more
  47 in total

1.  New inhibitory signaling by CTLA-4.

Authors:  Christoph Wülfing; Helen M Tunbridge; David C Wraith
Journal:  Nat Immunol       Date:  2014-05       Impact factor: 25.606

Review 2.  Intrinsic and extrinsic control of peripheral T-cell tolerance by costimulatory molecules of the CD28/ B7 family.

Authors:  Hélène Bour-Jordan; Jonathan H Esensten; Marc Martinez-Llordella; Cristina Penaranda; Melanie Stumpf; Jeffrey A Bluestone
Journal:  Immunol Rev       Date:  2011-05       Impact factor: 12.988

3.  CTLA-4 Immunohistochemistry and Quantitative Image Analysis for Profiling of Human Cancers.

Authors:  Charles Brown; Farzad Sekhavati; Ruben Cardenes; Claudia Windmueller; Karma Dacosta; Jaime Rodriguez-Canales; Keith E Steele
Journal:  J Histochem Cytochem       Date:  2019-10-14       Impact factor: 2.479

4.  Cytotoxic-T-lymphocyte antigen 4 receptor signaling for lymphocyte adhesion is mediated by C3G and Rap1.

Authors:  Yoel Kloog; Adam Mor
Journal:  Mol Cell Biol       Date:  2014-01-06       Impact factor: 4.272

5.  Cytotoxic T lymphocyte antigen 4 (CTLA4) gene polymorphism with bladder cancer risk in North Indian population.

Authors:  Praveen Kumar Jaiswal; Vibha Singh; Rama Devi Mittal
Journal:  Mol Biol Rep       Date:  2014-01-04       Impact factor: 2.316

6.  PVRIG and PVRL2 Are Induced in Cancer and Inhibit CD8+ T-cell Function.

Authors:  Sarah Whelan; Eran Ophir; Maya F Kotturi; Ofer Levy; Sudipto Ganguly; Ling Leung; Ilan Vaknin; Sandeep Kumar; Liat Dassa; Kyle Hansen; David Bernados; Benjamin Murter; Abha Soni; Janis M Taube; Amanda Nickles Fader; Tian-Li Wang; Ie-Ming Shih; Mark White; Drew M Pardoll; Spencer C Liang
Journal:  Cancer Immunol Res       Date:  2019-01-18       Impact factor: 11.151

7.  Role of the EHD Family of Endocytic Recycling Regulators for TCR Recycling and T Cell Function.

Authors:  Fany M Iseka; Benjamin T Goetz; Insha Mushtaq; Wei An; Luke R Cypher; Timothy A Bielecki; Eric C Tom; Priyanka Arya; Sohinee Bhattacharyya; Matthew D Storck; Craig L Semerad; James E Talmadge; R Lee Mosley; Vimla Band; Hamid Band
Journal:  J Immunol       Date:  2017-12-06       Impact factor: 5.422

8.  Association of CTLA4 gene polymorphism in Iranian patients with ankylosing spondylitis.

Authors:  Esfandiar Azizi; Ahmad Massoud; Ali Akbar Amirzargar; Mahdi Mahmoudi; Narjes Soleimanifar; Nima Rezaei; Ahmad Reza Jamshidi; Behrouz Nikbin; Mohammad Hossein Nicknam
Journal:  J Clin Immunol       Date:  2009-12-11       Impact factor: 8.317

9.  Defects in CTLA-4 are associated with abnormal regulatory T cell function in rheumatoid arthritis.

Authors:  Fabian Flores-Borja; Elizabeth C Jury; Claudia Mauri; Michael R Ehrenstein
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-26       Impact factor: 11.205

10.  Immature and maturation-resistant human dendritic cells generated from bone marrow require two stimulations to induce T cell anergy in vitro.

Authors:  Thomas G Berger; Hendrik Schulze-Koops; Michaela Schäfer; Ester Müller; Manfred B Lutz
Journal:  PLoS One       Date:  2009-08-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.